We have mvesugated the possible hepatic microsomal enzyme mduction effect of enflurane, administered by inhalation in anaesthetic doses for periods of 1 h a day. In 15 experimental groups, differing from one another in anaestheuc concentrauon (1,2 and 3% enflurane) and in the number of days of treatment (3,7, 10,14,21 and 24) we found (1) no alteration either in the rauo of liver to body weight or in the microsomal protein content; (2) no modificauons in aniline hydroxylase acuvity; (3) a decrease in the aminopynne demethylase activity after a number of exposures, varying with the dose.
Inhalation anaesthetics are metabolized by microsomal enzymes, located mainly in the liver, which are also responsible for the transformation of other xenobiotics and of some endogenous products (Van Dyke, 1973; Brown, 1976; HipohtoReis and Rocha-Reis, 1977; Cohen, 1978) . The synthesis of these enzymes can be induced by certain substances in an apparently non-specific way (Brown, 1973; Gillette, 1971) . The increase in the enzyme quantity may affect the biotransformation both of the inducer itself (autoinduction) and of other substances (cross-induction). Among the enzymatic inducers we have the inhalation anaesthetics, such as diethyl ether, fluroxene, halothane, methoxyflurane and isoflurane (Berman and Bochantin, 1970; Linde and Berman, 1971; Brown and Sagalyn, 1974) .
In this work, we have tried to determine the possible cross-induction capacity of enflurane, which itself is thought to be relatively resistant to biotransformation (Halsey et al., 1971; Cousins et al., 1976; Dooley et al., 1979) . Previous reports on this subject are limited (Linde and Berman, 1971; Berman et al., 1976) .
The results we obtained proved that, under the conditions we used, enflurane is not an enzyme inducer and they refute both the impression given by the literature that inhalation anaesthetics are generically inducers and the nowadays less plausible impression that their action on microsomal enzymic activities is a non-specific effect.
MATERIALS AND METHODS

Reagents and enzymes
All the reagents used were analar quality or the chemically purest ones available. The isocitric dehydrogenase, the isocitrate and the NADPH were supplied by Sigma (U.S.A.).
Laboratory animals
We used adult male, white Wistar rats, weights 225-300 g. These animals are supplied by the Biology Center of Fundacao Calouste Gulbenkian (Oeiras), weighing approximately lOOg, and they are kept in our Laboratory under conditions of continuous renewal of atmospheric air, constant temperature and humidity, with alternate 12-h periods of light (8-20 h) and of dark. The animals were given a suitable commercial diet, which has proved to be totally satisfactory, and water ad libitum. No insecticides were used.
The administration of the anaesthetic took place during 1 h a day, for periods varying from 3 to 24 days. The animals were placed inside a glass container of 10-litre capacity containing sodalime in a compartment made at the bottom with a drilled platform. There was a continuous renewal of gas atmosphere. Enflurane (Ethrane, Abbott Laboratories) was vaporized in air by an Enfluratec vaporizer (Cyprane, Ltd) and the concentration used were 1, 2 or 3%.
After the period of anaesthesia, the rats were placed again in their usual environment and were fed ad libitum.
To avoid the possibility of normal variations in enzymatic activities interfering with any treatment-related effects, all observations were compared with those of control animals which were treated identically except that they did not receive enflurane.
The experiments with administration of the anaesthetic for 3 days were carried out within a short period of time, while the other took place during a longer period. The control groups are, however, contemporaneous with the experiment groups.
The rats were killed with a guillotine 24 h after the last administration of anaesthetic. The liver was removed, its weight was registered and after cooling in micronized ice, the microsomes were prepared (Schenkman, Remmer and Estabrook, 1967) .
Analytical procedures
The incubation medium had the following final concentrations for both enzyme activity tests: Tris-HCl buffer 50 mmol litre" 1 , pH 7.5; magnesium chloride 5 mmol litre" 1 ; NADPH 1 mmol litre"'; isocitrate 5 mmol litre" 1 ; isocitric dehydrogenase 0.4u. ml" 1 ; in a final volume of 5 ml. The final protein concentration was 1.5 nig ml"' for the aniline hydroxylase test and 1 mg ml"' for the aminopyrine demethylase test. The mixture containing the microsomal suspension and the NADPH generating preparation was thermally equilibrated for 5 min and the enzyme reaction started with the addition of substrate: 8 mmol litre" 1 (final concentration) for aminopyrine and for aniline.
The incubations were carried out in an open atmosphere at 37 °C, in a shaking Dubnoff incubator. Specimens were removed after 0,5,10, 15 and 20 min. The reaction was stopped with the addition of trichloroacetic acid, 7.5% for aminopyrine and 15% for aniline, followed by the determination of formaldehyde (Nash, 1953) and of p-aminophenol (Kato and Gillette, 1965) respectively.
We had verified previously that, under the conditions used, the enzymic activity is proportional to the time of incubation, but in order that the tests could be compared it was necessary to use the same protein concentration.
The results were expressed in nmole of the product formed, per min and per mg of microsomal protein.
Protein assays
Protein contents were determined by the method of Lowry and others (1951) , Lab-Trol (Dade Diagnostic, Inc., U.S.A.) being used as standard.
Statistical analysis
Significance of difference between means was assessed by Student's t test.
RESULTS
Enflurane, in different concentration in the anaesthetic mixture, inhaled for 1 h a day for a variable number of days, did not show any hepatic microsomal enzymatic induction effect of the hydroxylase activity of aniline and of the demethylase activity of aminopyrine under the experimental conditions we used (table I) ; on the contrary, we found that, with inhalation for 1 h a day, there was a decrease in the demethylase activity of aminopyrine in the animals which inhaled 1 or 2% enflurane over 7 or more days or 3% enflurane over 3 days (P<0.05 in all cases). However, no significant differences were observed between these experimental groups of longer duration. The hydroxylase activity of aniline was not changed in any of the experimental groups.
We further verified that there was not any statistically significant variation in any group, either in the ratio of liver to body weight or in the hepatic microsomal protein content relative to either liver or body weight of the animal (table  ID- 
DISCUSSION
It is well known that enzyme inducers interfere in the metabolism and in the toxicity of certain general anaesthetics. The problem has been studied particularly in relation to the renal and hepatic toxicity of halothane, fluroxene, chloroform and methoxyfiurane (Shoeller, 1970; Brown, 1972; Cascorbi and Singh-Amaranath, 1973; Harrison and Smith, 1973; Reynolds and Moslen, 1974; .
Confirmation that there are inhalation anaesthetics with effects known as auto-induction and cross-induction is also of great interest (Van Dyke, 1966; Cohen, 1971) .
However, the published studies of the enzyme induction capacity of anaesthetics vary with experimental conditions. This makes their comparison and the estimation of their true relevance to toxicity very difficult.
The studies with diethyl ether, methoxyfiurane, halothane, fluroxene and isoflurane seem to prove the hepatic microsomal hydroxylase enzyme induction capacity of these substances, although in a non-uniform way. For example, diethyl ether acts as an inducer of the phenobarbitone type, increasing the components of the microsomal electron transport system (cytochrome P-450; NADPH-dependent reductase of cytochrome c; and cytochrome b5) and stimulates the metabolism of substrates of type I (hexobarbitone and 9.547±0.655(n: 4) 9.419±0 871 (n: 4) 7. 817±0.206(n: 4) 7.970 ± 1.767 (n:
•1) 8. 177±0.672(n: 8) 8.968±0.801 (n: 238±0.563(n: 10.743 ± 0.826 (n ; 9.557 ± 1.309 (n: 8.831 ±0.257 (n: 9.020 ±0 622 (n-9 568 ± 0.460 (n = 9.309±0.661 (n = 8.m±0 .672(n 9.082±0.822(n; 385±3.487(n-4) aminopyrine) and of type II (aniline) (Brown and Sagalyn, 1974) . There are other more selective anaesthetics since they affect only some of those processes (Brown, 1971; Davis et al., 1971; Linde and Berman, 1971; Brown and Sagalyn, 1974; Takahashi, Shigematsu and Furukawa, 1974) . Published information on the cross-induction effects of the administration of enflurane in vxvo is scarce and incomplete. Its induction capacity has not been confirmed by direct determination of enzyme activities, such as has been performed in this study.
Our results (tables I and II) allow us to conclude that, when administered in vivo and under the conditions described, enflurane (1) does not show any hepatic microsomal enzyme induction capacity and does not profoundly or lastingly interfere with the microsomal protein content; (2) after a certain number of exposures varying the dose, it modifies the metabolism of aminopyrine through the isolated microsomes and inhibits it.
These results confirm the following conclusions drawn from the literature: (1) not every inhalation anaesthetic shows the same hepatic microsomal enzyme inductive capacity; (2) when present, it is not necessarily a non-specific effect; and (3) some even have inhibitory properties or properties that repress the microsomal enzyme activities. In fact, halothane and methoxyflurane, for instance, when administered in vivo, do not modify the metabolism of aniline (substrate type II) and they have also in common the effect of decreasing the metabolism of hexobarbitone and of ethylmorphine (substrates type I); they differ, however, in that halothane decreases the NADPH-dependent reductase activity of cythochrome c, while methoxyflurane increases it (Davis et al., 1971; Brown and Sagalyn, 1974) .
The mechanism by which enflurane initiates the decrease of metabolism of aminopyrine (table  I), has not yet been determined, and we do not think it a simple one.
If the likelihood is confirmed that enflurane in man is not an enzyme inducer, and if it is ascertained that it is not effectively an autoinducer and does not deeply and lastingly interfere with the microsomal protein structure, then these facts, together with its apparent metabolic stability (Chase et al., 1971; Halsey et al., 1971; Cousins et al., 1976; Dooley et al., 1979) , support the safety of its clinical use.
In contrast, verification of an effect that may be repressive or inhibitory of microsomal metabolic activity (the demethylation of aminopyrine) and dependent on dosage and repetition of administration, would point in another direction.
